Armata Pharmaceuticals (ARMP) Retained Earnings: 2013-2018
Historic Retained Earnings for Armata Pharmaceuticals (ARMP) over the last 5 years, with Sep 2018 value amounting to -$402.0 million.
- Armata Pharmaceuticals' Retained Earnings fell 2.59% to -$402.0 million in Q3 2018 from the same period last year, while for Sep 2018 it was -$402.0 million, marking a year-over-year decrease of 2.59%. This contributed to the annual value of -$394.2 million for FY2017, which is 3.37% down from last year.
- According to the latest figures from Q3 2018, Armata Pharmaceuticals' Retained Earnings is -$402.0 million, which was down 0.40% from -$400.4 million recorded in Q2 2018.
- Over the past 5 years, Armata Pharmaceuticals' Retained Earnings peaked at -$360.3 million during Q3 2015, and registered a low of -$402.0 million during Q3 2018.
- In the last 3 years, Armata Pharmaceuticals' Retained Earnings had a median value of -$391.1 million in 2017 and averaged -$386.3 million.
- In the last 5 years, Armata Pharmaceuticals' Retained Earnings climbed by 6.00% in 2014 and then decreased by 5.84% in 2017.
- Over the past 5 years, Armata Pharmaceuticals' Retained Earnings (Quarterly) stood at -$362.0 million in 2014, then fell by 0.14% to -$362.5 million in 2015, then decreased by 5.20% to -$381.4 million in 2016, then fell by 3.37% to -$394.2 million in 2017, then declined by 2.59% to -$402.0 million in 2018.
- Its Retained Earnings stands at -$402.0 million for Q3 2018, versus -$400.4 million for Q2 2018 and -$397.3 million for Q1 2018.